Accès à distance ? S'identifier sur le proxy UCLouvain
90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study
Primary tabs
| Document type | Communication à un colloque (Conference Paper) – Abstract, Présentation orale avec comité de sélection |
|---|---|
| Publication date | 2007 |
| Language | Anglais |
| Conference | "49th Annual Meeting of the American-Society-of-Hematology", Atlanta(Ga) (Dec 08-11, 2007) |
| Journal information | "Blood" - Vol. 110, no. 11, p. 14A-15A (2007) |
| Peer reviewed | yes |
| issn | 0006-4971 |
| e-issn | 1528-0020 |
| Publisher | Amer Soc Hematology (Washington) |
| Affiliation | UCL - Autre |
| Links |
| Bibliographic reference | Gisselbrecht, Christian ; Decaudin, Didier ; Mounier, Nicolas ; Tilly, Herve ; Ribrag, Vincent ; et. al. 90Yttrium ibritumomab tiuxetan (Zevalin) combined with BEAM (Z-BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory. follicular lymphoma. GELA phase II study.49th Annual Meeting of the American-Society-of-Hematology (Atlanta(Ga), Dec 08-11, 2007). In: Blood, Vol. 110, no. 11, p. 14A-15A (2007) |
|---|---|
| Permanent URL | http://hdl.handle.net/2078.1/59331 |